WuXi NextCode Restructures, Rebrands as Genuity Science
NEW YORK – Multinational bioinformatics and sequencing firm WuXi NextCode has rebranded itself Genuity Science as it announced plans to restructure as a single entity while it sheds its Chinese operations.
Genuity Science will continue to offer contract genomics and artificial intelligence-driven data sourcing and data analytics services to the biopharmaceutical industry to support drug discovery and development. The company is headquartered in Boston and has offices in Reykjavik, Iceland, and Dublin, as well as CAP-accredited, CLIA-certified sequencing laboratories in Woburn, Massachusetts, and Dublin.
This website stores cookies on your computer. Some of these cookies enable this website to function and some of these cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy and Privacy Policy.
